Combining Antidepressants for Enhanced Efficacy

Introduction to Combination Therapy

The American College of Physicians recommends modifying treatment if inadequate response occurs within 6-8 weeks of initiating fluoxetine monotherapy 1
The American Academy of Child and Adolescent Psychiatry suggests that fluoxetine's longer half-life requires patience when assessing response to dose adjustments, with monitoring at 1-2 week intervals initially for adverse effects and suicidality 1, 2

Bupropion augmentation is associated with significantly lower rates of sexual dysfunction compared to fluoxetine or sertraline monotherapy, as recommended by the American College of Physicians 1, 3
The American College of Physicians advises monitoring for increased agitation, irritability, or unusual behavioral changes indicating worsening depression, as well as suicidal thoughts and behaviors, particularly during the first 1-2 months of treatment 1

The American Academy of Child and Adolescent Psychiatry recommends against waiting indefinitely for monotherapy response, with evidence supporting modification at 6-8 weeks 1
The American College of Physicians warns against assuming all augmentation strategies are equivalent, with bupropion specifically outperforming buspirone for depression severity reduction, and advises against overlooking drug interactions, such as bupropion's induction of CYP3A4, which may affect oral contraceptives and immunosuppressants 1, 3

The American College of Physicians guideline addresses augmentation with bupropion, showing that augmenting an SSRI with bupropion decreased depression severity more than buspirone, though with no difference in response or remission rates 4, 5, 6
Moderate-quality evidence demonstrated that discontinuation due to adverse events was lower with bupropion than with buspirone when used as augmentation 4, 6
Low-quality evidence showed no difference in suicidal ideation, behavior, or serious adverse events when augmenting with bupropion 4, 5

No significant increase in serious adverse events compared to monotherapy 4, 6
Lower discontinuation rates due to adverse events compared to some other augmentation strategies like buspirone 4, 6

Switching to a different SSRI or SNRI showed no difference in response rates compared to switching to bupropion 5, 6
Augmentation with cognitive therapy showed comparable outcomes to medication augmentation 4, 5
Consider atypical antipsychotic augmentation or other evidence-based strategies 4

The American College of Physicians recommends modifying treatment if inadequate response occurs within 6-8 weeks of fluoxetine monotherapy, as this combination targets different neurotransmitter systems and significantly reduces depression severity while offering the critical advantage of lower sexual dysfunction rates compared to fluoxetine monotherapy 7

Continue treatment for 4-9 months after achieving satisfactory response in patients with a first episode of major depressive disorder, and consider years to lifelong maintenance therapy for patients with two or more prior episodes, as recommended by the American College of Physicians 7
Maintain the same dosage that achieved remission during the continuation phase to prevent relapse, according to the American College of Physicians 7

Monitor intensively for agitation, irritability, or unusual behavioral changes that may indicate worsening depression, particularly during the first 1-2 months of combination therapy, as advised by the American College of Physicians 7
Assess for increased suicidal thoughts and behaviors at 1-2 week intervals initially, and watch for emergence of activation symptoms that could signal treatment failure rather than success, as recommended by the American College of Physicians 7

Avoid premature discontinuation before allowing adequate time (6-8 weeks) to assess combination efficacy, as recommended by the American College of Physicians 7
Do not overlook the sexual dysfunction advantage of bupropion when counseling patients about augmentation options, according to the American College of Physicians 7